Observation of a cohort of 400 patients with different types of lymphomas.
Patients over the age of 15 years and 3 months, diagnosed with lymphoma at Nîmes University Hospital as from 1999 onwards and for whom diagnostic tumor material is available.
Patients aged 18 or over who have expressed their desire not to take part in the study.
Patients under the age of 18 whose legal representatives have expressed their desire for the child not to take part in the study.
Patients under legal guardianship.
The population consists of patients with lymphomas (Malignant Non-Hodgkinien and Hodgkin Lymphomas) diagnosed at Nîmes University Hospital from 1999 onwards and for whom the frozen biological samples are available. Since 2005, all patients have been registered in the Tumototek software program. Those diagnosed before this date can be found in the hospital's anatomopathological laboratory registers.
Cohort
Retrospective
Not listed
Overall survival rate among patients with Hodgkin Lymphomas
The number of months during which the patient has survived since inclusion will be noted. If the patient has died, the date of death recorded in the hospital file or from the INSERM CépiDC register will be noted.
Overall survival rate among patients with Mantle-cell Lymphomas
The number of months during which the patient has survived since inclusion will be noted.If the patient has died, the date of death recorded in the hospital file or from the INSERM CépiDC register will be noted.
Overall survival rate among patients with Primitive Cerebral Lymphomas
The number of months during which the patient has survived since inclusion will be noted. If the patient has died, the date of death recorded in the hospital file or from the INSERM CépiDC register will be noted.
Overall survival rate among patients with Follicular Lymphomas
The number of months during which the patient has survived since inclusion will be noted. If the patient has died, the date of death recorded in the hospital file or from the INSERM CépiDC register will be noted.
Differences between management of patients with Hodgkin Lymphomas actually observed and data described in the literature.
The actual management of these patients will be compared with the data in the literature and any differences will be noted.
Differences between management of patients with Mantle-cell Lymphomas and data described in the literature.
The actual management of these patients will be compared with the data in the literature and any differences will be noted.
Differences between management of patients with Primitive Cerebral Lymphomas and data described in the literature.
The actual management of these patients will be compared with the data in the literature and any differences will be noted.
Differences between management of patients with Follicular Lymphomas and data described in the literature.
The actual management of these patients will be compared with the data in the literature and any differences will be noted.
Click on the lead sponsor to view all of their trials.
